Skip to content

Efficacy and safety analysis of ciprofol for controlled hypotension in nasal endoscopic surgery

Efficacy and safety analysis of ciprofol for controlled hypotension in nasal endoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099160
Enrollment
Unknown
Registered
2025-03-19
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasosinusitis

Interventions

Ciprofol Group:0.4 mg/kg was induced with ciprofol, and ciprofol pump at a constant rate, with an initial dose of 0.8 mg/kg/h and a range of 0.4~2.4 mg/(kg·h).
Propofol group:Propofol was used to induce 2 mg/kg,and propofol was used to pump at a constant rate, with an initial dose of 6.0 mg/(kg·h) and a range of 4~12 mg/(kg·h).

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective nasal endoscopic surgery 2. Gender is not limited, age >= 18 years old and <= 65 years old; 3. American Society of Anesthesiologists (ASA) Class I or II; 4. 18kg/m^2<= BMI <=30kg/m^2; 5. Inform the patient and his family of the anesthesia plan and risks, and the patient agrees to anesthesia and signs the informed consent form for clinical trials.

Exclusion criteria

Exclusion criteria: 1. Patients with hypertension (uncontrolled hypertension or SBP>160mmHg and/or DBP>100mmHg after treatment with antihypertensive drugs 2. Those who have a history of allergy to anesthetic drugs (benzodiazepines, propofol, etc.) and have contraindications to general anesthesia; 3. Inform the anesthesia plan and risks, and patients who cannot be accepted for controlled blood pressure; 4. Those who have mental and nervous system diseases and are unable to think independently and communicate normally; 5. Those with a history of drug abuse, alcoholism, and long-term use of sedatives, pain relievers, and sleeping pills; 6. Patients who have undergone nasal endoscopic surgery in the past 3 months; 7. other reasons could not be included in the study.

Design outcomes

Primary

MeasureTime frame
Success rate of controlled hypotension;

Secondary

MeasureTime frame
Field quality score;Hemodynamic index at different time points (heart rate,non-invasive blood pressure, saturation of pulse oximetry);Dosage of anesthetic drugs;Operation duration;Duration of anesthesia;awakening time;extubation time;Time to target blood pressure;

Countries

China

Contacts

Public ContactChen Mi

Affiliated Hospital of Guizhou Medical University

147459443@qq.com+86 139 8408 3222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026